Testosterone replacement therapy is now available through two distinct channels: telehealth providers that manage care remotely and in-person practices that deliver treatment through face-to-face appointments. Both models can provide guideline-concordant treatment for diagnosed hypogonadism, but they differ in how patients access evaluations, receive prescriptions, and complete follow-up monitoring.

The practical gap between these models has narrowed. A 2022 review in the International Journal of Impotence Research found that telemedicine offers a viable mechanism for AUA guideline-concordant TRT management, noting increased access for patients who face geographic or scheduling barriers (Ory et al., 2022). For men weighing their options through a telehealth hormone provider, the deciding factors tend to be cost structure, convenience, privacy, and the depth of ongoing monitoring, not the standard of care itself. This article covers the meaningful differences between online TRT and in-person testosterone therapy so that patients can make informed decisions alongside their providers.

How Does In-Person Testosterone Therapy Work?

In-person testosterone therapy follows the traditional outpatient model. A patient schedules an appointment at a men's health practice, completes intake paperwork, and meets with a provider face-to-face during business hours. Laboratory draws may happen on-site or at a referred draw station. Follow-up visits to review results and adjust protocols require additional in-person trips.

The diagnostic laboratory standard is the same regardless of setting, though the method of clinical evaluation differs. The AUA Testosterone Deficiency Guideline requires symptoms or signs consistent with testosterone deficiency plus confirmed low serum testosterone on at least two separate early-morning measurements (Mulhall et al., 2018). The Endocrine Society guidelines align on this standard, recommending that providers confirm consistently low concentrations before initiating therapy (Bhasin et al., 2018).

In-person settings may offer a direct physical examination during the initial evaluation, which some providers consider valuable when assessing testicular volume or screening for physical findings that inform the diagnostic workup. Follow-up monitoring typically occurs every three to six months, with labs covering hematocrit, PSA, estradiol, and testosterone levels.

How Telehealth TRT Providers Operate

Telehealth TRT providers deliver the same category of care through virtual channels. Patients complete online intake forms, receive lab orders for national draw-site networks, and consult with licensed providers by phone or video. Medications ship directly to the patient's home.

A critical regulatory note: testosterone is a Schedule III controlled substance under the Anabolic Steroid Control Act. The Ryan Haight Act generally requires at least one in-person evaluation before internet prescribing. However, a temporary DEA flexibility permits telemedicine prescribing without that initial in-person visit through December 31, 2026 (DEA Fourth Temporary Extension, 2026). Permanent rules remain pending, and state requirements vary.

The diagnostic laboratory requirements do not change in a telehealth setting. Two early-morning testosterone draws, clinical symptom evaluation, and a licensed provider's determination of medical appropriateness are still required before any prescription is written (Mulhall et al., 2018). Legitimate telehealth providers do not guarantee prescriptions, approve all applicants, or bypass laboratory confirmation.

Online TRT vs In-Person Testosterone Therapy at a Glance

Both channels require the same laboratory panels and follow the same clinical guidelines.

Cost Differences Between Online and In-Person TRT

Cost is one of the most common reasons patients compare these models, but direct apples-to-apples pricing is difficult to pin down. In-person practices often bill per visit, with separate charges for consultations, laboratory work, and medications. Some accept insurance, which may reduce out-of-pocket costs but introduces variability through copays and prior authorizations.

Telehealth providers more commonly operate on a direct-pay or subscription model, bundling consultations, lab coordination, and medications into a single recurring fee. This structure tends to produce more predictable monthly costs. However, patients should verify what each fee includes before enrolling. Practices that advertise a low entry price without disclosing medication costs, lab fees, or cancellation terms raise legitimate transparency concerns.

Regardless of channel, responsible pricing disclosure should state what is and is not included. Direct-pay patients may be eligible to use HSA or FSA funds. Patients considering different formulation types should also factor in how the delivery method affects overall cost, since injectable testosterone cypionate, topical formulations, and other ester options carry different price profiles.

Is Telehealth TRT as Medically Sound as In-Person Care?

When managed by a qualified provider who follows established guidelines, telehealth TRT can meet the same diagnostic and prescribing standard as in-person care. The deciding factor is the provider, not the delivery channel.

Both models should include proper diagnostic confirmation (two early-morning testosterone draws plus symptom evaluation), a licensed prescribing provider, ongoing lab monitoring at regular intervals, and honest risk disclosure. The TRAVERSE trial, a randomized controlled study of 5,246 men with hypogonadism and preexisting or high cardiovascular risk, found that testosterone replacement therapy was noninferior to placebo for major adverse cardiac events (MACE occurred in 7.0% of the testosterone group vs 7.3% of the placebo group) (Lincoff et al., 2023). However, the testosterone group showed higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism. Following these results, the FDA issued class-wide labeling changes in February 2025 that added blood-pressure monitoring information and retained the limitation of use for age-related testosterone decline (FDA, 2025).

Any provider, regardless of setting, should disclose these risks and maintain regular monitoring. Red flags in either model include prescribing without reviewing laboratory results, providing identical dosing regardless of individual labs, failing to require follow-up bloodwork, or making outcome guarantees.

Lab and Monitoring Standards Across Both Models

The AUA Testosterone Deficiency Guideline and the Endocrine Society guideline apply equally regardless of whether the prescribing provider is across a desk or across a screen.

Ongoing monitoring should include hematocrit (testosterone may increase red blood cell concentration, and guidelines flag levels above the recommended threshold as a point requiring dose reduction or therapeutic phlebotomy), PSA, estradiol, blood markers affecting hormonal balance, and blood pressure per the 2025 FDA labeling update. Follow-up labs are typically recommended within the first three to six months after initiation, then at regular intervals.

Patients should also understand that exogenous testosterone can suppress spermatogenesis. Fertility preservation should be discussed with the prescribing provider before initiating therapy, for men of reproductive age. Adjunctive medications such as hCG or enclomiphene, used off-label, may help support fertility goals, though outcomes vary and neither approach guarantees maintained sperm production.

An additional sourcing distinction applies: branded FDA-approved testosterone products have undergone formal regulatory review, while compounded testosterone (prepared by 503A or 503B pharmacies) is not FDA-approved. Patients should confirm whether their prescribed formulation is FDA-approved or compounded, as the regulatory status and quality assurance processes differ.

Privacy, Geographic Access, and Scheduling

Three practical differences separate the models beyond clinical quality.

Privacy is a common reason patients choose telehealth. Consultations happen from home, medications arrive in unmarked packaging, and there is no shared waiting room. For men in smaller communities or in professions where medical privacy carries professional weight, this can matter.

Geographic access is another factor. In-person practices serve a limited radius. Telehealth providers can offer coverage across multiple states (subject to licensing), which benefits patients in rural areas or those who relocate frequently.

Scheduling flexibility also differs. In-person appointments generally fall within weekday business hours. Many telehealth providers offer evening and weekend availability, reducing the need for time away from work.

When Does In-Person Testosterone Therapy Make More Sense?

In-person care remains the better fit in certain situations. Patients who have complex medical histories may benefit from a direct physical examination during the initial evaluation. Men who are uncomfortable self-administering injections may prefer practices that offer in-office administration. Some patients simply value face-to-face interaction with their provider, and that preference is clinically valid.

Patients whose insurance covers in-network visits at an in-person practice may also find cost advantages in that model, though most TRT care across both channels tends to be direct-pay. In all cases, the diagnostic and monitoring standards remain the same.

When Is Online TRT the Stronger Fit?

For many patients, telehealth TRT addresses the most common barriers to consistent care: scheduling conflicts, travel time, geographic isolation, and privacy concerns. Patients who prefer predictable monthly costs may find the bundled direct-pay model easier to manage. Those who relocate frequently benefit from treatment continuity across state lines (where the provider is licensed).

The key consideration is choosing a telehealth provider that follows guideline-concordant care. Evaluation by a licensed provider, laboratory confirmation of testosterone deficiency, prescribed only when medically appropriate, and ongoing monitoring are not optional steps in either model. Marek Health's personalized lab approach follows this standard, building treatment plans around individual diagnostic results and clinical evaluation rather than fixed protocols.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

Is online TRT as safe as in-person testosterone therapy? 

Both models follow the same diagnostic and monitoring standards set by the AUA and Endocrine Society. Safety depends largely on the provider's adherence to guidelines and the depth of ongoing monitoring, not the delivery channel alone. The TRAVERSE trial found that testosterone therapy was noninferior to placebo for major adverse cardiac events in men with hypogonadism and high cardiovascular risk, though secondary signals including atrial fibrillation and pulmonary embolism were higher in the testosterone group (Lincoff et al., 2023).

What lab work is required before starting TRT? 

Clinical guidelines require at least two separate early-morning testosterone measurements confirming low levels, plus symptoms consistent with testosterone deficiency (Mulhall et al., 2018). Additional baseline labs typically include hematocrit, PSA, estradiol, and a lipid panel. Both telehealth and in-person providers should complete this workup as part of an individualized evaluation before prescribing.

Does online TRT cost less than in-person testosterone therapy? 

Telehealth providers often use bundled direct-pay pricing that includes consultations, lab coordination, and medications. In-person practices more commonly bill per service, with separate charges for each component. Actual cost depends on the specific provider, formulation prescribed, and whether insurance applies. Patients should verify what each fee includes before committing to a plan.

Can telehealth providers legally prescribe testosterone online? 

Testosterone is a Schedule III controlled substance. A temporary DEA flexibility permits telemedicine prescribing without an initial in-person visit through December 31, 2026. Permanent rules are pending, and state-level requirements vary. Patients should confirm that any telehealth provider operates within both federal and state regulations applicable to their location.

Does testosterone therapy affect fertility? 

Exogenous testosterone can suppress spermatogenesis, which may reduce sperm production during therapy. Fertility preservation should be discussed with the prescribing provider before starting TRT, for men of reproductive age. Adjunctive medications such as hCG or enclomiphene, used off-label, may help support sperm production, though outcomes vary by individual and no approach guarantees maintained fertility (Bhasin et al., 2018).

What monitoring is needed while on TRT? 

Regardless of whether care is delivered online or in person, ongoing monitoring should include hematocrit, PSA, estradiol, blood pressure (per the 2025 FDA labeling update), and testosterone levels. Follow-up labs are typically recommended within the first three to six months, then at regular intervals. The 2025 FDA labeling changes added blood-pressure monitoring information following the TRAVERSE trial results (FDA, 2025).

Is compounded testosterone the same as FDA-approved testosterone? 

No. FDA-approved testosterone products have undergone formal regulatory review for safety and efficacy. Compounded testosterone, prepared by 503A or 503B pharmacies, is not FDA-approved and differs in regulatory status and quality assurance processes. Patients should confirm whether their prescribed formulation is FDA-approved or compounded, and providers should disclose this distinction clearly.

References

• N Engl J Med. 2023;389(2):107–117

• J Urol. 2018;200(2):423–432

• J Clin Endocrinol Metab. 2018;103(5):1715–1744

• Int J Impot Res. 2022;34(7):663–668